Hritvik Jain, Andrew M. Goldsweig/LinkedIn
Oct 29, 2025, 07:09
Hritvik Jain and Andrew Goldsweig Shared Risk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
Hritvik Jain, Founding President of EnigmaMed Research Initiative, shared a post on X:
“In our latest publication in The Canadian Journal of Cardiology (CJC), we report risk of MACCE, AMI, and readmission in IBD patients undergoing PCI! Thanks to Andrew M. Goldsweig guidance and mentorship”
Title: Outcomes of Percutaneous Coronary Intervention in Patients with Inflammatory Bowel Disease: A Propensity-Score Matched Analysis
Authors: Hritvik Jain, Nandan Patel, Jyoti Jain, Kriti Soni, Siddharth P. Agrawal, Bala Pushparaji, Richard Malone, Mohammed Absar Ullah, Andrew M. Goldsweig
Read full article here.
Stay informed with Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI